Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications Median time to relapse was 7.4 ...
Standardization of 18F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma We analyzed patients with relapse after ES-HL treated ...
Ace the Case: First Relapse After Quadruplet Therapy: CAR T Selection, Bridging, and Toxicity Timing
Previously reserved for heavily pretreated patients in the late stages of relapse, CAR T-cell therapy is now regarded as an effective option for achieving deep, durable responses in some patients with ...
Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...
For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...
Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results